Charles McWherter, Senior Vice President at CymaBay Therapeutics, Inc. (CBAY), bought 3,000 shares at $1.68 ($5K) on 2016-04-15, disclosed to the SEC on 2016-04-19.
Open-market purchase of $5k CBAY by Senior Vice President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| CBAY | SELL | 2024-01-22 | $752K | — | Filing → |
| CBAY | SELL | 2023-12-18 | $487K | — | Filing → |
| CBAY | SELL | 2023-11-17 | $415K | — | Filing → |